Try

USANA Health Sciences Inc. Common Stock

USNAUnited States

5 filed reports · 298 financial concepts · 4 earnings calls · 0 media appearances

Filed reports

5 reports · Jun 2025 to Jul 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR4931Jun 2025 to Jul 2026
Annual · 10-KSEC EDGAR11,007Jan 2026

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJul 4, 2026Aug 13, 2026352Open
FY2026 Q110-QApr 4, 2026May 12, 2026235Open
FY202510-KJan 3, 2026Mar 16, 20261,007Open
FY2025 Q310-QSep 27, 2025Nov 5, 2025236Open
FY2025 Q210-QJun 28, 2025Aug 5, 2025108Open

Financial data

298 concepts · 1,938 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial284 concepts · 1,598 facts · Dec 2022 to Jul 2026

  • Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations15 · Dec 2022 to Jul 2026
  • Stockholders equity (US GAAP)15 · Dec 2022 to Jul 2026
  • Cash and cash equivalents at carrying value13 · Dec 2023 to Jul 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jul 2026
  • Restricted cash noncurrent13 · Dec 2023 to Jul 2026
  • Adjustments related to tax withholding for share based compensation12 · Dec 2023 to Jul 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Dec 2023 to Jul 2026
  • Brand Partner incentives12 · Dec 2023 to Jul 2026
  • Comprehensive income net of tax12 · Dec 2023 to Jul 2026
  • Comprehensive income net of tax attributable to noncontrolling interest12 · Dec 2023 to Jul 2026
  • Comprehensive income net of tax including portion attributable to noncontrolling interest12 · Dec 2023 to Jul 2026
  • Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jul 2026
  • Depreciation depletion and amortization12 · Dec 2023 to Jul 2026
  • Equity securities without readily determinable fair value impairment loss annual amount12 · Dec 2023 to Jul 2026
  • Gross profit (US GAAP)12 · Dec 2023 to Jul 2026
  • Income tax expense benefit12 · Dec 2023 to Jul 2026
  • Incremental common shares attributable to share based payment arrangements12 · Dec 2023 to Jul 2026
  • Interest expense nonoperating12 · Dec 2023 to Jul 2026
  • Investment income interest12 · Dec 2023 to Jul 2026
  • Net income loss12 · Dec 2023 to Jul 2026
  • Net income loss attributable to redeemable noncontrolling interest12 · Dec 2023 to Jul 2026
  • Nonoperating income expense12 · Dec 2023 to Jul 2026
  • Operating expenses (US GAAP)12 · Dec 2023 to Jul 2026
  • Operating income loss12 · Dec 2023 to Jul 2026

Segment13 concepts · 249 facts · Dec 2023 to Jul 2026

  • Depreciation depletion and amortization36 · Dec 2023 to Jul 2026
  • Brand Partner incentives32 · Dec 2023 to Jul 2026
  • Cost of goods and services sold (US GAAP)32 · Dec 2023 to Jul 2026
  • Operating income loss32 · Dec 2023 to Jul 2026
  • Revenue32 · Dec 2023 to Jul 2026
  • Selling general and administrative expense32 · Dec 2023 to Jul 2026
  • Amortization of intangible assets23 · Dec 2023 to Jul 2026
  • Goodwill foreign currency translation gain loss12 · Dec 2024 to Jul 2026
  • Goodwill impairment loss8 · Jan 2026 to Jul 2026
  • Goodwill acquired during period3 · Dec 2024
  • Goodwill and intangible asset impairment3 · Jan 2026
  • Restructuring charges3 · Jan 2026
  • Percentage of consolidated net sales during the year1 · Mar 2026

Geography1 concepts · 91 facts · Dec 2023 to Jul 2026

  • Revenue91 · Dec 2023 to Jul 2026

Segments

340 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments5 members · 247 facts

  • All Other69 · Dec 2023 to Jan 2026
  • Hiya69 · Dec 2023 to Jul 2026
  • Core Nutritional54 · Dec 2023 to Jul 2026
  • Rise31 · Mar 2025 to Jul 2026
  • Direct Selling24 · Jun 2024 to Sep 2025

Statement geographical8 members · 91 facts

  • Americas And Europe12 · Dec 2023 to Jul 2026
  • Asia Pacific12 · Dec 2023 to Jul 2026
  • CN12 · Dec 2023 to Jul 2026
  • Greater China12 · Dec 2023 to Jul 2026
  • North Asia12 · Dec 2023 to Jul 2026
  • Southeast Asia Pacific12 · Dec 2023 to Jul 2026
  • US12 · Dec 2023 to Jul 2026
  • KR7 · Dec 2023 to Jan 2026

Subsegments1 member · 2 facts

  • Buy Sell Reporting Unit2 · Jan 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

4 calls · Oct 2025 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 5, 2026
  • FY2026 Q1May 6, 2026
  • FY2025 Q4Feb 18, 2026
  • FY2025 Q3Oct 23, 2025

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

USANA Health Sciences Inc. Common Stock (USNA) data · FactIQ